10 BÜCHER, DIE MIT «AROMATASE INHIBITOR» IM ZUSAMMENHANG STEHEN
Entdecke den Gebrauch von
aromatase inhibitor in der folgenden bibliographischen Auswahl. Bücher, die mit
aromatase inhibitor im Zusammenhang stehen und kurze Auszüge derselben, um seinen Gebrauch in der Literatur kontextbezogen darzustellen.
68 Stein RC, Dowsett M, Hedley A, Ford HT, Gazet JC, Coombes RC (1990)
Preliminary study of the treatment of advanced breast cancer in postmenopausal
women with aromatase inhibitor CGS 16949A. Cancer Res 50: 1381–1384 69 ...
Angela Brodie, B.J.A. Furr, Aman Buzdar, 2008
2
Managing Breast Cancer Risk
The aromatase inhibitor alone is more effective than tamoxifen in reducing
primary breast cancer, but increases fractures because estrogen is denied to all
sites that contain ER. A combination of an aromatase inhibitor, anastrozole, and a
...
3
Early Breast Cancer: From Screening to Multidisciplinary ...
The median follow-up from MA-17 is only 2.5 years, and so it is reasonable to
recommend a minimum of 2.5 years of an aromatase inhibitor after completion of
tamoxifen treatment, especially in those with node-positive disease. 4. Do the IES
...
Guidubaldo Querci della Rovere, Ruth Warren, John R. Benson, 2005
4
Clinical Reproductive Medicine and Surgery
A major advantage of an aromatase inhibitor used alone is the ability to achieve
restoration of monofollicular ovulation in anovulatory infertility (e.g., PCOS) with
either multiple102,103,105 or single-dose147 regimens of aromatase inhibitor ...
Tommaso Falcone, William W. Hurd, 2007
5
Current Medicinal Chemistry
In vivo studies have shown that exemestane is a potent, orally active aromatase
inhibitor, and is presently in clinical trials for the treatment of advanced breast
cancer in postmenopausal women [41]. Numazawa et al. have recently reported
on ...
6
Principles and Practice of Chemotherapy
Aromatase inhibitor: Aromatase inhibitor: Aromatase inhibitor: Aromatase
inhibitor: Aromatase inhibitor: We know in postmenopausal women major source
of estrogen is from adrenal gland it produces androestradian which gets
converted into ...
7
Aromatase Inhibition and Breast Cancer
Potency and selectivity of the non- steroidal aromatase inhibitor CGS 1 6949A in
postmenopausal breast cancer patients. Clin Endocrinol 1990; 32:623-624. 5.
Coombes RC, Goss P, Dowsett M, Gazet JC, Brodie A. 4-
hydroxyandrostenedione ...
William R. Miller, Richard Santen, 2000
8
Biological and Hormonal Therapies of Cancer
Comparison of the selective aromatase inhibitor formestane with tamoxifen as
first-line hormonal therapy in postmenopausal women with advanced breast
cancer. Ann Oncol 5 (Suppl 7):S19-S24. 94. Coombes RC. Goss PE. Dowsett M ...
Kenneth A. Foon, Hyman B. Muss, 1998
9
Breast Cancer: A Practical Guide
As initial adjuvant therapy, based on the results of the ATAC Trial: – An
aromatase inhibitor is a reasonable alternative to tamoxifen. – An aromatase
inhibitor is the treatment of choice for J with a contraindication to tamoxifen. –
There are not ...
Orlando E. Silva, Stefano Zurrida, 2005
10
Handbook of Neurochemistry and Molecular Neurobiology: ...
Moreover, in breeding males, experimental treatment with an aromatase inhibitor
or ER antagonist decreased aggression, but a 5α-reductase inhibitor and AR
antagonist had no effect (Schlinger and Callard, 1990). Taken together, these
data ...
Jeff Blaustein, Abel Lajtha, 2007
10 NACHRICHTEN, IN DENEN DER BEGRIFF «AROMATASE INHIBITOR» VORKOMMT
Erfahre, worüber man in den einheimischen und internationalen Medien spricht und wie der Begriff
aromatase inhibitor im Kontext der folgenden Nachrichten gebraucht wird.
Top 10 Highlights from ASCO 2015
Anastrozole Trumps Tamoxifen in DCIS: Treatment of postmenopausal women with ductal carcinoma in situ (DCIS) with the aromatase inhibitor ... «Cancer Network, Jul 15»
FDA's TRT Censorship Creates Opportunity For Lipocine (LPCN)
Novartis is currently developing BGS649, an aromatase inhibitor, as a testosterone therapy for the treatment of obese, hypogonadotropic ... «Seeking Alpha, Jul 15»
Embryo cryopreservation possible for women with breast cancer
(HealthDay News) -- For women with breast cancer, embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation ... «Oncology Nurse Advisor, Jun 15»
Top Takeaways from ASCO: Breast Cancer
Key opinion leaders offer their views on positive results from trials investigating an adjunct endocrine therapy, an aromatase inhibitor as an ... «Healio, Jun 15»
Embryo Cryopreservation Feasible for Women With Breast Cancer
For women with breast cancer, embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility, ... «Doctors Lounge, Jun 15»
Adjuvant Radiotherapy in Low-Risk Breast Cancer Patients: Review …
... hormone receptor status, lymph node status), and systemic treatment (tamoxifen/aromatase inhibitor utilization) characteristics and to identify ... «OncLive, Jun 15»
Protecting personalised medicine at the EPO
The board held that the tumours of patients first treated with tamoxifen and subsequently with an aromatase inhibitor acquired resistance first to ... «Lexology, Jun 15»
NCI CTEP-Approved Trials for the Month of June
NCIC-MA.27G-BAYLOR-ICSC: The Role of Vitamin D and Inflammatory Cytokines in Mediating Aromatase Inhibitor-Induced Arthralgia: An ... «The Cancer Letter Publications, Jun 15»
Phase III Prolia Trial Meets Endpoint in Clinical Fractures in Breast …
... in postmenopausal women with early hormone receptor positive breast cancer receiving aromatase inhibitor therapy met its primary endpoint ... «The Cancer Letter Publications, Jun 15»
Daiichi Sankyo Espha to launch 7 new generic drugs with 4 new …
... Letrozole tablets 2.5mg “DSEP” (Femara tablets 2.5mg) Aromatase inhibitor/postmenopausal breast cancer treatment; Oxaliplatin IV infusion ... «pharmabiz.com, Jun 15»
